For example: Apple Inc, UTIL, Aluminum
MIRAGEN THERAPEUTICS, INC.
NASDAQ:MGEN
Market Close 11/27
16.93 USD +0.72 (+4.44%)
OPEN:
16.36
DAY RANGE:
16.36 - 17.12
PE:
-1.59
PB:
1.82
PS:
14.75
WTD % -1.80
MTD % 1,192.37
QTD % 2,084.52
YTD % 3,427.82
* Updated at market close
MIRAGEN THERAPEUTICS, INC. (NASDAQ:MGEN) opened on Nov 27, 2020 at 16.36 USD and edged higher by 4.44%. The intraday price range was 16.36 - 17.12 USD and eventually ended the session at 16.93 USD. The stock trade volume was 41,500.00 shares. The company's 52-week range is 0.31 - 20.50 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 63.89 M
Outstanding Stock 30.84 M
Dividend 0.00
Dividend Yield 0.00
EPS -1.29
YTD Change 3,427.82%
52 Week's Range 0.31 - 20.50
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -1.59
Price/Book Value 1.82
Price/Sales 14.75
ROA -
ROE -
Debt/Equity 0.46
Company Self Description
Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. The company's product include cobomarsen, an inhibitor of microRNA-155, which is in Phase I clinical trial for treating cutaneous T-cell lymphoma; MRG-201, a replacement for microRNA-29, which is in Phase I clinical trial that is found at low levels in various pathological fibrotic conditions, including cutaneous, cardiac, renal, hepatic, and pulmonary fibrosis. It was founded in 2006 and is headquartered in Boulder, Colorado, United States.
Business Information
MIRAGEN THERAPEUTICS, INC.
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  MGEN ANIX GNCA SNGX
Daily Change (%) 4.44 21.93 3.48 5.83
WTD (%) -1.80 25.79 1.46 -0.91
MTD (%) 1,192.37 34.95 0 28.24
QTD (%) 2,084.52 14.40 -9.17 21.79
YTD (%) 3,427.82 -15.24 0.48 50.34
52-Week Change (%) 2,261.23 -28.53 -10.34 109.62
Stock Performance (Market Close Nov 27, 2020)
  MGEN ANIX GNCA SNGX
Daily Change (%) 4.44 21.93 3.48 5.83
WTD (%) -1.80 25.79 1.46 -0.91
MTD (%) 1,192.37 34.95 0 28.24
QTD (%) 2,084.52 14.40 -9.17 21.79
YTD (%) 3,427.82 -15.24 0.48 50.34
52-Week Change (%) 2,261.23 -28.53 -10.34 109.62
Key Fundamentals (Market Close Nov 27, 2020)
  MGEN ANIX GNCA SNGX
Market Cap 63.89 M 63.87 M 62.33 M 65.07 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -925.50% -2,971.30% 0.00 -171.60%
P/E Ratio -1.59 -4.25 -1.74 -1.42
Price to Sales Ratio 14.75 133.37 0 2.57
Price to Book Ratio 1.82 13.93 3.39 2.42
Enterprise Value to EBITDA -2.28 -5.23 -0.18 -0.39
ROA - -260.20% -66.60% -82.20%
ROE - -306.10% -202.00% -142.70%
Debt/Equity 0.46 0.23 3.24 0.67
Asset Turnover Ratio 0.07 0.09 0 0.48
Current Ratio 9.71 4.38 2.52 2.46
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 8.39 M 4.00 M 3.48 M 2.54 M
Cost Of Revenue 0.00 0.00 0.00 2.47 M
Gross Profit 8.39 M 4.00 M 3.48 M 66,000.00
Selling General & Administrative Expenses 11.05 M 10.91 M 6.77 M 10.25 M
Research & Development 30.42 M 19.62 M 13.69 M 1.00 M
Operating Income -33.08 M -26.53 M -16.99 M -11.19 M
Net Income -32.70 M -26.51 M -17.27 M -11.33 M
EPS -1.10 -1.38 -28.21 -21.02
Diluted EPS -1.10 -1.38 -28.21 -21.02
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 2.51 M 372,000.00 476,000.00 944,000.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 2.51 M 372,000.00 476,000.00 944,000.00
Selling General & Administrative Expenses 2.86 M 3.36 M 2.70 M 2.70 M
Research & Development 8.60 M 8.75 M 8.23 M 7.40 M
Operating Income -8.94 M -11.74 M -10.45 M -9.15 M
Net Income -8.90 M -11.63 M -10.32 M -9.01 M
EPS -0.29 -0.38 -0.33 -0.29
Diluted EPS -0.29 -0.38 -0.33 -0.29
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 65.37 M 51.87 M 23.88 M 11.73 M
Cash & Cash Equivalents 32.61 M 47.44 M 22.10 M 10.83 M
Total Assets 66.15 M 52.48 M 24.76 M 12.90 M
Total Current Liabilities 6.73 M 3.90 M 6.89 M 2.47 M
Total Liabilities 14.80 M 13.97 M 9.71 M 2.49 M
Shareholder's Equity 51.34 M 38.51 M -61.92 M 10.41 M
Outstanding Stock 30.84 M 22.31 M 719,721.00 709,385.00
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 48.08 M 54.21 M 65.37 M 75.75 M
Cash & Cash Equivalents 24.01 M 18.20 M 32.61 M 31.70 M
Total Assets 48.78 M 54.95 M 66.15 M 76.55 M
Total Current Liabilities 9.15 M 6.86 M 6.73 M 6.83 M
Total Liabilities 15.35 M 13.99 M 14.80 M 15.84 M
Shareholder's Equity 33.44 M 40.96 M 51.34 M 60.72 M
Outstanding Stock 30.93 M 30.92 M 30.84 M 30.60 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -26.84 M -28.17 M -14.76 M -6.90 M
Capital Expenditures -445,000.00 -246,000.00 -250,000.00 -123,000.00
Net Cash Flow from Investing Activities -29.91 M 1.03 M -250,000.00 -95,000.00
Net Cash Flow from Financial Activities 41.92 M 52.47 M 15.87 M 12.71 M
Free Cash Flow -27.29 M -28.41 M -15.01 M -7.02 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -7.17 M -28.17 M -14.76 M -6.90 M
Capital Expenditures -32,000.00 -37,000.00 -51,000.00 -205,000.00
Net Cash Flow from Investing Activities 13.03 M -2.82 M 9.09 M -6.01 M
Net Cash Flow from Financial Activities -39,000.00 218,000.00 -10,000.00 1.11 M
Free Cash Flow -7.21 M -11.85 M -8.23 M -7.01 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -1.59 -2.16 -2.76 -5.42
Price to Sales Ratio 14.75 21.68 10.70 18.84
Price to Book Ratio 1.82 6.04 -0.06 0.76
Enterprise Value to EBIT -2.00 -7.00 0.00 0.00
Enterprise Value to EBITDA -2.28 -7.48 0.04 0.28
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -42.00% -51.10%
ROE - - -51.80% -63.60%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 58.64 M 47.97 M 16.99 M 9.27 M
Current Ratio 9.71 13.31 3.47 4.75
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.46 0.36 -0.16 0.24
Asset Turnover Ratio - - 0.11 0.08
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.